Results for tag: "Allylglycine"

Allylglycine is a drug used in the treatment of central nervous system (CNS) disorders. It is a derivative of glycine, an amino acid, and is believed to act as a modulator of the neurotransmitter glutamate. Allylglycine has been studied for its potential to treat a variety of CNS disorders, including schizophrenia, bipolar disorder, and depression. It has also been studied for its potential to treat anxiety, attention deficit hyperactivity disorder (ADHD), and Alzheimer's disease. Allylglycine is available in both oral and intravenous forms, and is typically administered in combination with other medications. It is generally well-tolerated, with few reported side effects. The allylglycine market is a rapidly growing segment of the CNS drug market. It is expected to continue to grow as more research is conducted into its potential therapeutic applications. Some companies in the allylglycine market include Merck, Pfizer, Novartis, and GlaxoSmithKline. Show Less Read more